J. C. Rodríguez Rey
433
74.
Dong, B., Saha, P.K., Huang, W., Chen, W., Abu-‐Elheiga, L.A., Wakil, S.J., Stevens, R.D.,
Ilkayeva, O., Newgard, C.B., Chan, L., et al. 2009. Activation of nuclear receptor CAR
ameliorates diabetes and fatty liver disease.
Proc Natl Acad Sci U S A
106:18831-‐18836.
75.
Lee, J.M., Lee, Y.K., Mamrosh, J.L., Busby, S.A., Griffin, P.R., Pathak, M.C., Ortlund, E.A., and
Moore, D.D. 2011. A nuclear-‐receptor-‐dependent phosphatidylcholine pathway with
antidiabetic effects.
N ture
474:506-‐510.
76.
Anstee, Q.M., and Day, C.P. 2012. A lipid to treat non-‐alcoholic fatty liver disease -‐ the
dawn of 'lipo-‐rehabilitation'?
J Hepatol
56:987-‐989.
